Table 1 Patient characteristics.
Characteristics | Categorical variables | Characteristics | Continuous variables | |
|---|---|---|---|---|
(percentage) | (mean ± standard) | |||
Gender | Male | 55(82.09%) | Age (years) | 55.22 ± 10.81 |
Female | 12(17.91%) | AFP (ng/mL) | 3192.06 ± 10962.96 | |
Smoking | Yes | 48(71.64%) | CEA (ng/mL) | 2.91 ± 1.59 |
No | 19(28.36%) | |||
Drinking | Yes | 13(19.40%) | CA199 (U/mL) | 32.74 ± 38.64 |
No | 54(80.60%) | |||
HBeAg | Negative | 51(76.12%) | ALT (U/L) | 69.15 ± 85.77 |
Positive | 16(23.88%) | |||
Child-Pugh grade | A | 63(94.03%) | AST (U/L) | 63.49 ± 66.20 |
B | 4(5.97%) | |||
Number of tumors | 1 | 57(85.07%) | ALB (g/L) | 41.66 ± 5.18 |
2 | 7(10.45%) | TBIL (umol/L) | 14.33 ± 9.10 | |
> 2 | 3(4.48%) | DBIL (umol/L) | 6.73 ± 5.76 | |
Vascular invasion | No | 56(83.58%) | ||
Yes | 11(16.42%) | IBIL (umol/L) | 7.60 ± 4.53 | |
Invasion of the liver capsule | No | 13(19.40%) | RGT (µ/L) | 110.36 ± 138.92 |
Yes | 54(80.60%) | AKP (U/L) | 107.49 ± 72.35 | |
Histopathological grading | Low | 13(19.40%) | PT (sec) | 13.29 ± 1.40 |
Intermediate | 49(73.13%) | WBC (×10^9/L) | 6.73 ± 2.77 | |
High | 5(7.46%) | |||
TNM stage | I | 33(49.25%) | PLT (×10^9/L) | 212.46 ± 155.53 |
II | 22(32.84%) | |||
III | 11(16.42%) | Hb (g/L) | 141.58 ± 17.33 | |
IV | 1(1.49%) | |||
Postoperative treatment modalities | RFA | 2(2.99%) | Maximum diameter of primary tumor (cm) | 7.16 ± 4.67 |
TACE | 30(44.78%) | |||
N/A | 35(52.24%) | |||
